Neuro-oncological precision nanomedicines
神经肿瘤精密纳米药物
基本信息
- 批准号:EP/R024723/1
- 负责人:
- 金额:$ 109.99万
- 依托单位:
- 依托单位国家:英国
- 项目类别:Research Grant
- 财政年份:2018
- 资助国家:英国
- 起止时间:2018 至 无数据
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
According to the world health organisation, the incidence of brain tumours has been rising steadily (up to forty percent) since the late 1970s. World-wide deaths in 2012 were recorded as 189,382 and are predicted to rise by a further twenty-five percent by 2020. Brain tumours are the most common solid tumour in children and the second most common cancer after leukaemia representing twenty-five percent of all primary paediatric tumours, the leading cause of cancer death. Despite the advances in imaging and multi- modality therapy with neurosurgery, radiotherapy and conventional cytotoxic chemotherapy, outcomes for high-risk brain tumours have improved little in the last two decades. When treatments are effective, they are associated with both acute and long-term significant treatment-related side effects. One of the chief obstacles hindering effective therapy for brain tumours is that the brain is very much isolated from the rest of the body with well-gated barriers controlling the trafficking of molecules and macromolecules in and out. In particular, the interface between the circulatory system and the brain tissues, (the blood-brain barrier (BBB) is the largest barrier by surface area, and allows short distance between blood and neural tissue. On top of this, one of the most critical limitations for cancer therapy is our inability to direct anticancer drugs to cancerous cells maximising killing and minimising side effects (often worse than the disease itself). This is due to the fact that cancer cells are the same healthy cells gone wrong and hence share many similarities with the good cells complicating detection and targeting.We propose here the design of ultra-small carriers (as small as a virus and 100 times smaller than cancer cells) that will be equipped with unique chemical signature to target almost exclusively the BBB, cross it, and target brain cancer cells. These nanocarriers will also be able to carry different drugs and deliver them right inside the cells where the drug is most effective.
根据世界卫生组织的数据,自20世纪70年代末以来,脑肿瘤的发病率一直在稳步上升(高达40%)。2012年全球死亡人数为189,382人,预计到2020年将进一步上升25%。脑肿瘤是儿童中最常见的实体肿瘤,也是继白血病之后的第二大常见癌症,占所有原发性儿科肿瘤的25%,是癌症死亡的主要原因。尽管影像学和神经外科、放疗和常规细胞毒性化疗的多模态治疗取得了进展,但在过去二十年中,高危脑肿瘤的结局几乎没有改善。当治疗有效时,它们与急性和长期显著的治疗相关副作用相关。阻碍脑肿瘤有效治疗的主要障碍之一是,大脑与身体的其他部分非常隔离,具有控制分子和大分子进出的门控屏障。特别地,循环系统和脑组织之间的界面(血脑屏障(BBB))是表面积最大的屏障,并且允许血液和神经组织之间的短距离。最重要的是,癌症治疗最关键的限制之一是我们无法将抗癌药物导向癌细胞,从而最大限度地杀死癌细胞并最大限度地减少副作用(通常比疾病本身更糟)。这是因为癌细胞是同样的健康细胞,因此与好的细胞有许多相似之处,使检测和靶向变得复杂。我们在这里提出了超小载体的设计(像病毒一样小,比癌细胞小100倍),它将配备独特的化学特征,几乎只靶向BBB,穿过它,靶向脑癌细胞。这些纳米载体也将能够携带不同的药物,并将它们输送到药物最有效的细胞内。
项目成果
期刊论文数量(10)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
On the design of precision nanomedicines
精密纳米药物的设计
- DOI:10.26434/chemrxiv.5647969
- 发表时间:2019
- 期刊:
- 影响因子:0
- 作者:Battaglia G
- 通讯作者:Battaglia G
Targeting Macrophages and Synoviocytes Intracellular Milieu to Augment Anti-Inflammatory Drug Potency
- DOI:10.1002/adtp.202100167
- 发表时间:2022-01-10
- 期刊:
- 影响因子:4.6
- 作者:Gouveia, Virginia M.;Rizzello, Loris;Battaglia, Giuseppe
- 通讯作者:Battaglia, Giuseppe
Design principles for precision targeting
精确瞄准的设计原则
- DOI:10.26434/chemrxiv.5647969.v2
- 发表时间:2018
- 期刊:
- 影响因子:0
- 作者:Battaglia G
- 通讯作者:Battaglia G
Bottom-Up Evolution of Vesicles from Disks to High-Genus Polymersomes.
- DOI:10.1016/j.isci.2018.08.018
- 发表时间:2018-09-28
- 期刊:
- 影响因子:5.8
- 作者:Contini C;Pearson R;Wang L;Messager L;Gaitzsch J;Rizzello L;Ruiz-Perez L;Battaglia G
- 通讯作者:Battaglia G
A Multiscale Study of Phosphorylcholine Driven Cellular Phenotypic Targeting.
磷酸胆碱驱动的细胞表型靶向的多尺度研究。
- DOI:10.1021/acscentsci.2c00146
- 发表时间:2022-07-27
- 期刊:
- 影响因子:18.2
- 作者:Acosta-Gutierrez, Silvia;Matias, Diana;Avila-Olias, Milagros;Gouveia, Virginia M.;Scarpa, Edoardo;Forth, Joe;Contini, Claudia;Duro-Castano, Aroa;Rizzello, Loris;Battaglia, Giuseppe
- 通讯作者:Battaglia, Giuseppe
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Giuseppe Battaglia其他文献
Beyond Structure. Imaging Protein Dynamics at Physiological Temperatures
- DOI:
10.1016/j.bpj.2020.11.1219 - 发表时间:
2021-02-12 - 期刊:
- 影响因子:
- 作者:
Silvia Acosta Gutierrez;Gabriele Marchello;Cesare De Pace;Gabriel Ing;Ciro Lopez Vazquez;Simona Pilotto;Finn Werner;Neil Wilkinson;Francesco L. Gervasio;Lorena Ruiz-Perez;Giuseppe Battaglia - 通讯作者:
Giuseppe Battaglia
The Wnt Antagonist, Dickkopf-1, as a Target for the Treatment of Neurodegenerative Disorders
- DOI:
10.1007/s11064-008-9710-0 - 发表时间:
2008-04-22 - 期刊:
- 影响因子:3.800
- 作者:
Filippo Caraci;Carla Busceti;Francesca Biagioni;Eleonora Aronica;Federica Mastroiacovo;Irene Cappuccio;Giuseppe Battaglia;Valeria Bruno;Andrea Caricasole;Agata Copani;Ferdinando Nicoletti - 通讯作者:
Ferdinando Nicoletti
Correction to: Developmental up-regulation of NMDA receptors in the prefrontal cortex and hippocampus of mGlu5 receptor knock-out mice
- DOI:
10.1186/s13041-021-00822-6 - 发表时间:
2021-07-16 - 期刊:
- 影响因子:2.900
- 作者:
Tiziana Imbriglio;Remy Verhaeghe;Nico Antenucci;Stefania Maccari;Giuseppe Battaglia;Ferdinando Nicoletti;Milena Cannella - 通讯作者:
Milena Cannella
GERD with oropharingeal picture: A prospective therapeutical one-year study
- DOI:
10.1016/s0016-5085(00)80744-1 - 发表时间:
2000-04-01 - 期刊:
- 影响因子:
- 作者:
Francesco Di Mario;Nadia Dal Bo’;Simonetta Salandin;Marilisa Franceschi;Fabio Vianello;Giuseppe Battaglia;Gaetano Mastropaolo;Alessandro Caroli;Alberto Pilotto - 通讯作者:
Alberto Pilotto
Exploitation of seawater brines for the production of Nesquehonite solids and COsub2/sub utilization
利用海水卤水生产三水菱镁矿固体以及二氧化碳的利用
- DOI:
10.1016/j.jcou.2025.103101 - 发表时间:
2025-06-01 - 期刊:
- 影响因子:8.400
- 作者:
Giuseppe Battaglia;Michela Cardella;Alessandro Tamburini;Andrea Cipollina;Giorgio Micale - 通讯作者:
Giorgio Micale
Giuseppe Battaglia的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Giuseppe Battaglia', 18)}}的其他基金
Personalised nanomedicine for cancer therapy
用于癌症治疗的个性化纳米医学
- 批准号:
EP/N026322/1 - 财政年份:2016
- 资助金额:
$ 109.99万 - 项目类别:
Fellowship
Video Liquid Transmission Electron Microscopy
视频液体透射电子显微镜
- 批准号:
EP/N010906/1 - 财政年份:2015
- 资助金额:
$ 109.99万 - 项目类别:
Research Grant
POLYMER NANOMEDICINE: ENHANCING THE TRANSLATION FROM THE LAB TO THE CLINIC
聚合物纳米医学:加强从实验室到临床的转化
- 批准号:
EP/I001697/1 - 财政年份:2010
- 资助金额:
$ 109.99万 - 项目类别:
Research Grant
Engineering Virus-like Nanoparticles for Targeting the Central Nervous System
用于靶向中枢神经系统的工程病毒样纳米颗粒
- 批准号:
EP/G062137/1 - 财政年份:2009
- 资助金额:
$ 109.99万 - 项目类别:
Research Grant
Polymeric vesicles with topologically controlled functionalities
具有拓扑控制功能的聚合物囊泡
- 批准号:
EP/E03103X/1 - 财政年份:2007
- 资助金额:
$ 109.99万 - 项目类别:
Research Grant
相似海外基金
Oncological Engineering - A new concept in the treatment of bone metastases
肿瘤工程——治疗骨转移的新概念
- 批准号:
EP/W007096/2 - 财政年份:2024
- 资助金额:
$ 109.99万 - 项目类别:
Research Grant
LEAPS-MPS: Deep Quasi-Reversibility Inversion for Source Localization Oncological Problems
LEAPS-MPS:源定位肿瘤问题的深度准可逆反演
- 批准号:
2316603 - 财政年份:2023
- 资助金额:
$ 109.99万 - 项目类别:
Standard Grant
Oncological significance of splenectomy and/or vagotomy focusing on the dynamics of patrolling monocytes
脾切除术和/或迷走神经切断术的肿瘤学意义侧重于巡逻单核细胞的动态
- 批准号:
23K15481 - 财政年份:2023
- 资助金额:
$ 109.99万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Understanding human Papilloma virus and Epstein-Barr virus related oncological mechanisms in head and neck squamous cell carcinoma
了解人乳头瘤病毒和 Epstein-Barr 病毒在头颈鳞状细胞癌中的相关肿瘤学机制
- 批准号:
463959 - 财政年份:2022
- 资助金额:
$ 109.99万 - 项目类别:
Operating Grants
Quantitative Oncological PET Image Generation and Analysis
定量肿瘤 PET 图像生成和分析
- 批准号:
RGPIN-2019-06467 - 财政年份:2022
- 资助金额:
$ 109.99万 - 项目类别:
Discovery Grants Program - Individual
Oncological Engineering - A new concept in the treatment of bone metastases
肿瘤工程——治疗骨转移的新概念
- 批准号:
EP/W007096/1 - 财政年份:2022
- 资助金额:
$ 109.99万 - 项目类别:
Research Grant
AI system for lymph node volume analysis in oncological imaging and therapy assessment
用于肿瘤成像和治疗评估中淋巴结体积分析的人工智能系统
- 批准号:
574196-2022 - 财政年份:2022
- 资助金额:
$ 109.99万 - 项目类别:
University Undergraduate Student Research Awards
Quantitative Oncological PET Image Generation and Analysis
定量肿瘤 PET 图像生成和分析
- 批准号:
RGPIN-2019-06467 - 财政年份:2021
- 资助金额:
$ 109.99万 - 项目类别:
Discovery Grants Program - Individual
Oncological significance of vagotomy in upper gastrointestinal surgery
迷走神经切断术在上消化道手术中的肿瘤学意义
- 批准号:
21K08740 - 财政年份:2021
- 资助金额:
$ 109.99万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Quantitative Oncological PET Image Generation and Analysis
定量肿瘤 PET 图像生成和分析
- 批准号:
RGPIN-2019-06467 - 财政年份:2020
- 资助金额:
$ 109.99万 - 项目类别:
Discovery Grants Program - Individual